Dosidal · South Korea

뷰라인정

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSouth Korea
Recordkr:presentation:kd:8806418040407 (version 1)
Levelpresentation
Pack codegtin: 08806418040407
Identifiersgtin: 08806418040407
kr-standard-code: 8806418040407
kr-mfds-item: 200901618
Source authorityHIRA / MFDS
Read date2026-11-15T05:00:21Z
authorisation statuscancelled_on: 2022-01-06
lifecycle: history
note: HIRA standard-code mapping status; MFDS authorisation status not read
state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page
controlled statuscategory: 해당사항없음
controlled: False
state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page
identityatc: A08AX
company: 광동제약(주)
ingredient_code: A03000ATB
item_approval_date: 2009-03-02
marking: 바코드
mfds_item_code: 200901618
product_name: 뷰라인정
serial_number_omitted: Y
serial_omission_reason: 일반의약품
spec: 200밀리그램
standard_code: 8806418040407
total_quantity: 0
state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page
pack product codecheck_digit_ok: True
gtin: 08806418040407
published_by: HIRA
representative_code: 8806418040407
standard_code: 8806418040407
state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page
prescription classas_published: 일반의약품
class: non_prescription
state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
3m8tjs03Jp7G6PJM5juwoUOpl9-twvZtJuTkfh5RHKzITYww-Z8AlGW_2TMYSbbEKvrBWJer7GrlLA3zjuqb0w
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/kr:presentation:kd:8806418040407 · Same medicine in other markets · Dosidal